Table of Contents

1 Study Coverage

• 1.1 Beta Glucan Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Beta Glucan Market Size Growth Rate by Product
  • 1.4.2 Soluble Beta-glucan
  • 1.4.3 Insoluble Beta-glucan
• 1.5 Market by End User
  • 1.5.1 Global Beta Glucan Market Size Growth Rate by End User
  • 1.5.2 Beverages
  • 1.5.3 Dairy Products
  • 1.5.4 Pharmaceuticals
  • 1.5.5 Bakery & Processed Food
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Beta Glucan Market Size
  • 2.1.1 Global Beta Glucan Revenue 2014-2025
  • 2.1.2 Global Beta Glucan Sales 2014-2025
• 2.2 Beta Glucan Growth Rate by Regions
  • 2.2.1 Global Beta Glucan Sales by Regions
  • 2.2.2 Global Beta Glucan Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Beta Glucan Sales by Manufacturers
  • 3.1.1 Beta Glucan Sales by Manufacturers
  • 3.1.2 Beta Glucan Sales Market Share by Manufacturers
  • 3.1.3 Global Beta Glucan Market Concentration Ratio (CR5 and HHI)
• 3.2 Beta Glucan Revenue by Manufacturers
  • 3.2.1 Beta Glucan Revenue by Manufacturers (2014-2019)
  • 3.2.2 Beta Glucan Revenue Share by Manufacturers (2014-2019)
• 3.3 Beta Glucan Price by Manufacturers
• 3.4 Beta Glucan Manufacturing Base Distribution, Product Types
  • 3.4.1 Beta Glucan Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Beta Glucan Product Type
  • 3.4.3 Date of International Manufacturers Enter into Beta Glucan Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Beta Glucan Sales by Product
• 4.2 Global Beta Glucan Revenue by Product
• 4.3 Beta Glucan Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Beta Glucan Breakdown Data by End User

6 North America

• 6.1 North America Beta Glucan by Countries
  • 6.1.1 North America Beta Glucan Sales by Countries
  • 6.1.2 North America Beta Glucan Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Beta Glucan by Product
• 6.3 North America Beta Glucan by End User

7 Europe

• 7.1 Europe Beta Glucan by Countries
  • 7.1.1 Europe Beta Glucan Sales by Countries
  • 7.1.2 Europe Beta Glucan Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Beta Glucan by Product
• 7.3 Europe Beta Glucan by End User

8 Asia Pacific

• 8.1 Asia Pacific Beta Glucan by Countries
  • 8.1.1 Asia Pacific Beta Glucan Sales by Countries
  • 8.1.2 Asia Pacific Beta Glucan Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Beta Glucan by Product
• 8.3 Asia Pacific Beta Glucan by End User

9 Central & South America

• 9.1 Central & South America Beta Glucan by Countries
  • 9.1.1 Central & South America Beta Glucan Sales by Countries
  • 9.1.2 Central & South America Beta Glucan Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Beta Glucan by Product
• 9.3 Central & South America Beta Glucan by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Beta Glucan by Countries
  • 10.1.1 Middle East and Africa Beta Glucan Sales by Countries
  • 10.1.2 Middle East and Africa Beta Glucan Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Beta Glucan by Product
• 10.3 Middle East and Africa Beta Glucan by End User

11 Company Profiles

• 11.1 Lesaffre
  • 11.1.1 Lesaffre Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Lesaffre Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Lesaffre Beta Glucan Products Offered
  • 11.1.5 Lesaffre Recent Development
• 11.2 DSM
  • 11.2.1 DSM Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 DSM Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 DSM Beta Glucan Products Offered
  • 11.2.5 DSM Recent Development
• 11.3 Bio Springer
  • 11.3.1 Bio Springer Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Bio Springer Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Bio Springer Beta Glucan Products Offered
  • 11.3.5 Bio Springer Recent Development
• 11.4 Lallemand
  • 11.4.1 Lallemand Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Lallemand Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Lallemand Beta Glucan Products Offered
  • 11.4.5 Lallemand Recent Development
• 11.5 Associated British Foods
  • 11.5.1 Associated British Foods Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Associated British Foods Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Associated British Foods Beta Glucan Products Offered
  • 11.5.5 Associated British Foods Recent Development
• 11.6 Biothera
  • 11.6.1 Biothera Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Biothera Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Biothera Beta Glucan Products Offered
  • 11.6.5 Biothera Recent Development
• 11.7 Tate & Lyle
  • 11.7.1 Tate & Lyle Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Tate & Lyle Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Tate & Lyle Beta Glucan Products Offered
  • 11.7.5 Tate & Lyle Recent Development
• 11.8 Garuda International
  • 11.8.1 Garuda International Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Garuda International Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Garuda International Beta Glucan Products Offered
  • 11.8.5 Garuda International Recent Development
• 11.9 Alltech
  • 11.9.1 Alltech Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Alltech Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Alltech Beta Glucan Products Offered
  • 11.9.5 Alltech Recent Development
• 11.10 Ceapro
  • 11.10.1 Ceapro Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Ceapro Beta Glucan Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Ceapro Beta Glucan Products Offered
  • 11.10.5 Ceapro Recent Development

12 Future Forecast

• 12.1 Beta Glucan Market Forecast by Regions
  • 12.1.1 Global Beta Glucan Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Beta Glucan Revenue Forecast by Regions 2019-2025
• 12.2 Beta Glucan Market Forecast by Product
  • 12.2.1 Global Beta Glucan Sales Forecast by Product 2019-2025
  • 12.2.2 Global Beta Glucan Revenue Forecast by Product 2019-2025
• 12.3 Beta Glucan Market Forecast by End User
• 12.4 North America Beta Glucan Forecast
• 12.5 Europe Beta Glucan Forecast
• 12.6 Asia Pacific Beta Glucan Forecast
• 12.7 Central & South America Beta Glucan Forecast
• 12.8 Middle East and Africa Beta Glucan Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Beta Glucan Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Beta Glucan is a significant functional ingredient that has various medical advantages. Its part in controlling hyperlipedemia and hyperglycemia is unprecedented.. The general purpose of beta glucan is to enhance and improve the human immune system. Currently, people are getting more aware and conscious about health food intake and boost their immune system, while performing these activities the demand of Beta-Glucan has increased globally.
Developing interest for nutraceutical and functional product is found in the most recent decade. This happened because of quick way of life and idea of curing illness through food. Individuals everywhere throughout the world have a mission for new choices and idea of functional ingredients fulfill their dietary needs as these positively affect metabolic parameters and eventually supportive in diseases, for example, cancer, diabetes and cardiovascular disease.
The global Beta Glucan market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Beta Glucan market based on company, product type, end user and key regions.

This report studies the global market size of Beta Glucan in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Beta Glucan in these regions.
This research report categorizes the global Beta Glucan market by top players/brands, region, type and end user. This report also studies the global Beta Glucan market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lesaffre
DSM
Bio Springer
Lallemand
Associated British Foods
Biothera
Tate & Lyle
Garuda International
Alltech
Ceapro

Market size by Product
Soluble Beta-glucan
Insoluble Beta-glucan
Market size by End User
Beverages
Dairy Products
Pharmaceuticals
Bakery & Processed Food
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Beta Glucan market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Beta Glucan market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Beta Glucan companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Beta Glucan submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Beta Glucan are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Beta Glucan market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.